Works matching DE "NEWCASTLE disease vaccines"


Results: 244
    1
    2

    Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 'Patria' vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1565934
    By:
    • Carballo-Uicab, Gregorio;
    • Mellado-Sánchez, Gabriela;
    • González-González, Edith;
    • Salinas-Trujano, Juana;
    • Mendoza-Salazar, Ivette;
    • López-Olvera, Karina;
    • Gómez-Castellano, Keyla M.;
    • Salazar, Ma. Isabel;
    • Torres-Flores, Jesús M.;
    • Chagoya-Cortés, Héctor Elías;
    • Paz-De la Rosa, Georgina;
    • Mena, Ignacio;
    • Rojas-Martínez, Oscar;
    • Lara-Puente, Jesús Horacio;
    • Peralta-Sánchez, Gustavo Javier;
    • Sarfati-Mizrahi, David;
    • Torres-Flores, Alejandro;
    • Sun, Weina;
    • Krammer, Florian;
    • García-Sastre, Adolfo
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13560-z
    By:
    • Díaz, Manolo Fernández;
    • Calderón, Katherine;
    • Rojas-Neyra, Aldo;
    • Vakharia, Vikram N.;
    • Choque-Guevara, Ricardo;
    • Montalvan-Avalos, Angela;
    • Poma-Acevedo, Astrid;
    • Rios-Matos, Dora;
    • Agurto-Arteaga, Andres;
    • Cauti-Mendoza, Maria de Grecia;
    • Perez-Martinez, Norma;
    • Isasi-Rivas, Gisela;
    • Tataje-Lavanda, Luis;
    • Sernaque-Aguilar, Yacory;
    • Ygnacio, Freddy;
    • Criollo-Orozco, Manuel;
    • Huaccachi-Gonzalez, Edison;
    • Delgado-Ccancce, Elmer;
    • Villanueva-Pérez, Doris;
    • Montesinos-Millán, Ricardo
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 683, p. 1, doi. 10.1126/scitranslmed.abo2847
    By:
    • Carreño, Juan Manuel;
    • Raskin, Ariel;
    • Singh, Gagandeep;
    • Tcheou, Johnstone;
    • Kawabata, Hisaaki;
    • Gleason, Charles;
    • Srivastava, Komal;
    • Vigdorovich, Vladimir;
    • Dambrauskas, Nicholas;
    • Gupta, Sneh Lata;
    • González Domínguez, Irene;
    • Martinez, Jose Luis;
    • Slamanig, Stefan;
    • Sather, D. Noah;
    • Raghunandan, Rama;
    • Wirachwong, Ponthip;
    • Muangnoicharoen, Sant;
    • Pitisuttithum, Punnee;
    • Wrammert, Jens;
    • Suthar, Mehul S.
    Publication type:
    Article
    42
    43
    44

    Formulation and Evaluation of Niosomes.

    Published in:
    Indian Journal of Pharmaceutical Sciences, 2011, v. 73, n. 3, p. 323
    By:
    • Okore, V. C.;
    • Attama, A. A.;
    • Ofokansi, K. C.;
    • Esimone, C. O.;
    • Onuigbo, E. B.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50